扶正理气合剂治疗抗结核药物性肝炎的临床研究

目的 探讨扶正理气合剂对抗结核药物性肝炎的临床疗效.方法 采用前瞻性研究,对2005年1月至2007年12月诊断为抗结核药物性肝炎100例住院患者随机分为治疗组和对照组,治疗组给予扶正理气合剂治疗,对照组进行常规治疗,疗效进行统计分析.结果 治疗组的疗效显著优于对照组.结论 扶正理气合剂可明显改善药物性肝炎的症状,恢复肝功能.

Clinical Study on Fuzheng-Liqi Mixture in the Treatment of Hepatitis Resulted from Anti-tuberculosis Drugs

Objective To explore the therapeutic effect of Fuzbeng-Liqi mixture on hepatitis resulted from anti-tuberculosis drugs.Methods 100 inpatients of hepatitis resulted from anti-tuberculosis drugs during January 2005 to December 2007 were randomly sorted out into a treatment group and a control group.The treatment group was treated with Fuzbeng-Liqi mixture,and the control group was treated with routine drugs.The effect was analyzed by 2/2 test.Results The therapeutic effect of the treatment group markedly excelled than the control group in terms of symptoms improvement such as nausea or vomit,tiredness,icterus,bepatalgia,or augment of liver.Conclusion Fuzbeng-Liqi mixture was not only able to ameliorate the clinical manifestations of drug-induced hepatitis,but also improve hepatic function.